KARABAY, A. Z. Et Al. 2017. Aspirin inhibits bcr-abl and its downstream effectors in chronic myeloid leukemia. VI. Molecular Medicine Congress , 55.

KARABAY, A. Z., KOÇ, A., hekmatshoar, y., KARADAĞ, A., & ÖZKAN, T., (2017). Aspirin inhibits bcr-abl and its downstream effectors in chronic myeloid leukemia . VI. Molecular Medicine Congress (pp.55).

KARABAY, ARZU Et Al. "Aspirin inhibits bcr-abl and its downstream effectors in chronic myeloid leukemia," VI. Molecular Medicine Congress, 2017

KARABAY, ARZU Z. Et Al. "Aspirin inhibits bcr-abl and its downstream effectors in chronic myeloid leukemia." VI. Molecular Medicine Congress , pp.55, 2017

KARABAY, A. Z. Et Al. (2017) . "Aspirin inhibits bcr-abl and its downstream effectors in chronic myeloid leukemia." VI. Molecular Medicine Congress , p.55.

@conferencepaper{conferencepaper, author={ARZU ZEYNEP KARABAY Et Al. }, title={Aspirin inhibits bcr-abl and its downstream effectors in chronic myeloid leukemia}, congress name={VI. Molecular Medicine Congress}, city={}, country={}, year={2017}, pages={55} }